CoChat

Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome

Lynn, Megan, Maclachlan, Laura, Finkelmeyer, Andreas, Clark, James, Locke, James, Todryk, Stephen, Ng, Wan-Fai, Newton, Julia L., Watson, Stuart · 2018 · Mediators of Inflammation
Cited by 13

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Glucocorticoid receptor (GR) function may have aetiopathogenic significance in chronic fatigue syndrome (CFS), via its essential role in mediating inflammatory responses as well as in hypothalamic-pituitary-adrenal axis regulation. GR function can be estimated ex vivo by measuring dexamethasone (dex) modulation of cytokine response to lipopolysaccharide (LPS), and in vivo using the impact of dex on cortisol levels. This study aimed to compare the GR function between CFS (n=48), primary Sjögren’s syndrome (a disease group control) (n=27), and sedentary healthy controls (HCs) (n=20), and to investigate its relationship with clinical measures. In the GR ex vivo response assay, whole blood was diluted and incubated with LPS (to stimulate cytokine production), with or without 10 or 100 nanomolar concentrations of dex. Cytometric bead array (CBA) and flow cytometry enabled quantification of cytokine levels (TNF α, interleukin- (IL-) 6, and IL-10) in the supernatants. In the in vivo response assay, five plasma samples were taken for determination of total cortisol concentration using ELISA at half-hourly intervals on two consecutive mornings separated by ingestion of 0.5 mg of dex at 11 pm. The association of the data from the in vivo and ex vivo analyses with reported childhood adversity was also examined. CFS patients had reduced LPS-induced IL-6 and TNF α production compared to both control groups and reduced suppression of TNF α by the higher dose of dex compared to HCs. Cortisol levels, before or after dex, did not differ between CFS and HCs. Cortisol levels were more variable in CFS than HCs. In the combined group (CFS plus HC), cortisol concentrations positively and ex vivo GR function (determined by dex-mediated suppression of IL-10) negatively correlated with childhood adversity score. The results do not support the hypothesis that GR dysregulation is aetiopathogenic in CFS and suggest that current and future endocrine cross-sectional studies in CFS may be vulnerable to the confounding influence of childhood trauma which is likely increased by comorbid depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2018/3972104

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 49

  1. 10.1093/qjmed/hcm057 · DOI · Paper page
  2. 10.1016/j.autrev.2008.08.003 · DOI · Paper page
  3. 10.7326/0003-4819-121-12-199412150-00009 · DOI · Paper page
  4. 10.1176/appi.ajp.160.2.221 · DOI · Paper page
  5. 10.1093/infdis/170.1.1 · DOI
  6. 2001, Psychological Medicine, 31, 1331, 10.1017/S0033291701004664 · DOI · Paper page
  7. 1990, Journal of Clinical Microbiology, 28, 1403, 10.1128/JCM.28.6.1403-1410.1990 · DOI · Paper page
  8. 10.1155/2013/784520 · DOI · Paper page
  9. 10.7150/ijms.12399 · DOI
  10. 10.1016/j.mehy.2008.11.044 · DOI
  11. 10.1097/00006842-199905000-00009 · DOI · Paper page
  12. 10.2310/6650.2001.34047 · DOI · Paper page
  13. 10.1034/j.1601-5215.2003.00033.x · DOI
  14. 10.1210/jcem-73-6-1224 · DOI · Paper page
  15. 10.1210/jc.2007-1747 · DOI · Paper page
  16. 10.1111/j.1600-0447.1998.tb10030.x · DOI · Paper page
  17. 10.1017/S0033291707001444 · DOI · Paper page
  18. 10.1097/00006842-200203000-00015 · DOI · Paper page
  19. 10.1016/j.psyneuen.2006.12.005 · DOI
  20. 10.1016/S0165-5728(01)00400-3 · DOI · Paper page
  21. 10.1086/517373 · DOI · Paper page
  22. 10.1097/PSY.0000000000000224 · DOI · Paper page
  23. 10.2217/14622416.7.3.475 · DOI
  24. 10.1111/j.1601-183X.2006.00244.x · DOI
  25. 10.1016/j.jad.2008.05.001 · DOI
  26. 10.1046/j.1365-2265.1998.00418.x · DOI · Paper page
  27. 10.1016/j.psyneuen.2004.06.008 · DOI
  28. 10.1111/j.1751-9861.2008.00033.x · DOI · Paper page
  29. 10.1001/archgenpsychiatry.2008.508 · doi:10.1001/archgenpsychiatry.2008.508 · Paper page
  30. 10.1196/annals.1366.014 · DOI · Paper page
  31. 10.1093/qjmed/93.6.323 · DOI · Paper page
  32. 10.1016/0091-3057(95)02127-2 · DOI
  33. 10.1023/A:1020558917955 · DOI
  34. 10.1016/S0022-3956(96)00063-5 · DOI · Paper page
  35. 1995, Structured Clinical Interview for DSM-IV Axis I disorders-Patient Edition
  36. 10.1136/ard.61.6.554 · DOI · Paper page
  37. 10.1093/rheumatology/keq240 · doi:10.1093/rheumatology/keq240
  38. 10.1093/occmed/kqp180 · DOI
  39. 10.1016/S0145-2134(02)00541-0 · DOI · Paper page
  40. 10.1093/clinids/18.Supplement_1.S79 · DOI · Paper page
  41. 10.1016/S0306-4530(02)00108-7 · DOI · Paper page
  42. 10.1016/j.euroneuro.2010.02.006 · DOI · Paper page
  43. 10.1111/j.1749-6632.2000.tb05453.x · DOI
  44. 2007, Neuropsychiatric Disease and Treatment, 3, 647
  45. 10.1038/nn1276 · DOI · Paper page
  46. 10.1038/nn.2270 · DOI · Paper page
  47. 10.1038/nature07455 · DOI · Paper page
  48. 10.1080/21641846.2018.1384095 · DOI
  49. 10.1186/s12920-017-0248-3 · DOI

Cited by

Metadata

Authors
Lynn, M., Maclachlan, L., Finkelmeyer, A., Clark, J., Locke, J., Todryk, S., Ng, W.-F., Newton, J. L., & Watson, S.
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2018-06-10
Volume
2018
Pages
1-11
ISSN
  • 0962-9351
  • 1466-1861
Cited by
13
References
16
Language
en
Funders
  • Action for ME (MR/J002712/1)
  • ME Research UK (MR/J002712/1)
  • Medical Research Council (MR/J002712/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.